# Viridian Therapeutics, Inc.\\DE: Form SCHEDULE 13D/A, filed May 13, 2026

- Company: [Viridian Therapeutics, Inc.\\DE](/companies/vrdn.md) (CIK 1590750)
- Form: SCHEDULE 13D/A
- Filed: 2026-05-13
- Accepted by EDGAR: May 13, 2026, 16:30 ET
- Period: not reported
- Accession: 0001104659-26-060292
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1590750/000110465926060292/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1590750/000110465926060292/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1590750/000110465926060292/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-060292. Last ingested by Listed: Nov 10, 2026, 17:36 ET. No prices; not investment advice.
